Drueke, B; Baetz, J; Boecker, M et al.
Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over studyPsychopharmacology (Berl). Bd. 207. H. 2. 2009 S. 213-23
Schanz, B; Stranz, S
DRG in der Psychiatrie und PsychosomatikDie Schwester Der Pfleger. Bd. 48. H. 12. 2009 S. 1229-1231
Waldschmitt, C; Vogel, F; Pfuhlmann, B et al.
Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) surveyPharmacopsychiatry. Bd. 42. H. 5. 2009 S. 189-193
Schroeder, A; Fahrenholz, F; Schmitt, U
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.J Alzheimers Dis. Bd. 16. H. 2. 2009 S. 309-14
Schulte-Herbrüggen, O; Fuchs, E; Ziegler, A et al.
Effects of escitalopram on the regulation of BDNF and NGF protein levels in a rat model of chronic stressJ Neurosci Res. Bd. 87. H. 11. 2009 S. 2551-2560
Jacob, GA; Hellstern, K; Ower, N et al.
Emotional reactions to standardized stimuli in women with borderline personality disorder: stronger negative affect, but no differences in reactivityJ Nerv Ment Dis. Bd. 197. H. 11. 2009 S. 808-15
Zernig, G; Hiemke, C; Havemann-Reinecke, U et al.
Empfehlungen für die gutachterliche Bewertung von Medikamentenspiegeln in der Psychiatrie im gerichtsanhängigen SchadensfallPsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 57-65
Konrad, A; Vucurevic, G; Musso, F et al.
ErbB4 genotype predicts left frontotemporal structural connectivity in human brainNeuropsychopharmacology. Bd. 34. H. 3. 2009 S. 641-650
Riss, PJ; Debus, F; Hummerich, R et al.
Ex vivo and in vivo Evaluation of [F-18]PR04.MZ in Rodents: A Selective Dopamine Transporter Imaging AgentCHEMMEDCHEM. Bd. 4. H. 9. 2009 S. 1480-1487
Bracht, T; Tuscher, O; Schnell, S et al.
Extraction of prefronto-amygdalar pathways by combining probability mapsPsychiatry Res. Bd. 174. H. 3. 2009 S. 217-22